Latest filing published 25 May 2022 for 东北制药, €75.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.6%Entry CN¥5.35 · Close at T+365 CN¥5.49
- +13.5%Entry CN¥5.19 · Close at T+365 CN¥5.89
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
刘琰: trading record in brief
刘琰 (chief executive) discloses dealings in 东北制药 to SSE / SZSE (CSRC). The record holds 2 filings, for trades running from 28 April 2022 to 25 May 2022.
No open-market sale appears; the market trades are 2 purchases worth €14k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 25 May 2022 came the latest disclosure, an open-market purchase for €75 in 东北制药. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 刘琰
Open company profiles for insider transactions, fundamentals and analyst consensus when available.